The Discounted Cash Flow (DCF) valuation of Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS) is 17.37 CNY. With the latest stock price at 26.40 CNY, the upside of Shanghai Fosun Pharmaceutical Group Co Ltd based on DCF is -34.2%.
Based on the latest price of 26.40 CNY and our DCF valuation, Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS) is a sell. selling 600196.SS stocks now will result in a potential gain of 34.2%.
| Range | Selected | |
| WACC / Discount Rate | 7.6% - 9.1% | 8.3% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 11.01 - 30.05 | 17.37 |
| Upside | -58.3% - 13.8% | -34.2% |